These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3088683)

  • 21. [Changes in the antigenic properties of strains of Neisseria meningitidis isolated from the cerebrospinal fluid of patients with meningitis].
    Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):91-9. PubMed ID: 3157468
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of neisseria.
    N Engl J Med; 1971 Nov; 285(19):1089. PubMed ID: 4999369
    [No Abstract]   [Full Text] [Related]  

  • 23. [New antigenic determination of Neisseria meningitidis. I. Results of serotyping of the strains N. meningitidis isolated in CSR in the years 1976-1978 from patients with cerebrospinal meningitis and from healthy carriers (author's transl)].
    Kuzemenská P; Svandová E
    Cesk Epidemiol Mikrobiol Imunol; 1980 Dec; 29(6):360-6. PubMed ID: 6450644
    [No Abstract]   [Full Text] [Related]  

  • 24. Erosive immune complex-mediated arthritis associated with meningococcal meningitis.
    Olivieri I; Pifferi M; Ceccarelli M; Puccetti A; Perri G; Ughi C; Ciompi ML
    Clin Rheumatol; 1986 Dec; 5(4):531-4. PubMed ID: 2949913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologic findings in meningoencephalitis caused by Neisseria meningitidis B 15, ECHO 4, and Angiostrongylus cantonensis].
    Dorta AJ; Ferra M; González N; Gutiérrez L; Escobar X; Díaz AG; Delahanty A; Romero R; Martín G; Campos M
    Rev Latinoam Microbiol; 1987; 29(3):287-91. PubMed ID: 3125574
    [No Abstract]   [Full Text] [Related]  

  • 26. 2nd international workshop on Neisseria vaccines (Neisseria vaccines 2009).
    Romeu B; González E; Campa C; Holst J; Pérez O
    Expert Rev Vaccines; 2009 Aug; 8(8):987-92. PubMed ID: 19627182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 30. False positive latex agglutination test with Neisseria meningitidis ACYW135 in a patient with intracranial dermoid tumor.
    Erdem G; Kanra G; Topçu M; Topaloglu H; Ceyhan M
    Pediatr Infect Dis J; 1994 Jun; 13(6):550-1. PubMed ID: 7521526
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of Neisseria meningitidis cell envelope antigen by enzyme-linked immunosorbent assay in patients with meningococcal disease.
    Sippel JE; Voller A
    Trans R Soc Trop Med Hyg; 1980; 74(5):644-8. PubMed ID: 6782717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningococcal carriage and immunity in western Burkina Faso, 2003.
    Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
    Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemoprevention in meningococcal meningitis. A health problem or a social response?].
    Garrido Morales P; Domínguez García A; Pumarola Busquets F
    Med Clin (Barc); 1985 Oct; 85(10):418-22. PubMed ID: 3935888
    [No Abstract]   [Full Text] [Related]  

  • 34. Surface proteins of pathogenic "Neisseria": antigenic variation and conserved epitopes.
    Meyer TF; Haas R; Stern A; Fiedler H; Frosch M; Jähnig F; Muralidharan K; Veit S
    Ann Sclavo Collana Monogr; 1986; 3(1-2):407-14. PubMed ID: 2447924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interpretation of the laboratory results concerning the protective effect of vaccines].
    Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA
    Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of anti-lactose antibodies from antisera to Neisseria gonorrhoeae and Neisseria meningitidis.
    Brakstad OG; Maeland JA
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):143-4. PubMed ID: 3929563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal antibodies against Neisseria gonorrhoeae elicited by Neisseria meningitidis.
    Cremieux AC; Puissant A; Ancelle R; Martin PM
    Lancet; 1984 Oct; 2(8408):930. PubMed ID: 6148649
    [No Abstract]   [Full Text] [Related]  

  • 39. Nature of the antigen present in the cerebrospinal fluid and serum of patients with group A meningococcal meningitis.
    Greenwood BM; Whittle HC
    Clin Exp Immunol; 1974 Mar; 16(3):413-7. PubMed ID: 4219838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.